Tagged with B

Japan A roundup of the most important stories coming out of Japan’s pharma industry, including the sharp increase in deaths linked to Kobayashi supplements; the partnership between Moderna and Mitsubishi Tanabe to jointly promote Moderna’s mRNA respiratory vaccine portfolio; the country’s move to to support domestic antibiotics production; Takeda’s licenscing agreement…

Mexico Drawing on an industry track record of over 25 years, Fernando Fogarin has recently become the strategic project lead for emerging markets at women’s health specialist Organon. He shares his priorities and the particularities of the Mexican market, discussing the positive impact of the country’s upcoming biosimilars reform; Organon’s efforts…

Brazil With the largest public healthcare system in the world, Latin America’s biggest pharma market, its leading regulatory body, and a huge and diverse population, Brazil is a strategic destination for both regional and global pharma. Read on for five things to watch in 2024 and beyond from this dynamic nation. …

Mexico Mexico’s president-elect Claudia Sheinbaum recently revealed some of her key cabinet choices, naming eminent physician and researcher David Kershenobich as the country’s new health secretary. When Kershenobich takes office in October he will be inheriting a healthcare system rife with medicine shortages, partially adopted systems and inadequate resources. However, rather…

Mexico The Mexican Diabetes Association (AMD) is an organization dedicated to providing education and training to Mexicans living with diabetes and their families. President Gabriela Allard comments on the importance of raising awareness in a country with a serious obesity problem, the AMD’s various educational and prevention programmes, and the lack…

USA The Promising Pathways Act 2.0 is a newly proposed bill that aims to expedite and streamline approval pathways for rare disease therapies in the US. The Act is, however, facing a number of challenges in terms of implementation. The sponsors of these niche therapies tend to be small and medium-sized…

China A roundup of some of the biggest pharma industry news from China, including Fosun’s bid for Henlius Biotech; the revision of the US’s Biosecure Act to provide more time for cutting ties with China; Baili Tianheng’s second Hong Kong listing; Hasten’s acquisition of asset rights for 14  products from Celltrion,…

Global 35 years after the specific mechanisms and structure of the human immunodeficiency virus were first identified, the world is still waiting for a vaccine against HIV. Several late-stage candidates have failed in this time, leading to most of the major pharma companies exiting HIV vaccine research. Some new early-stage approaches…

Saudi Arabia NUPCO, the centralised procurement body for healthcare products to Saudi Arabia’s government health sector, has embarked on a major digital transformation initiative over the past three years. CEO Fahad Al Shebel outlines its scope and impact, NUPCO’s role in localising insulin manufacturing in Saudi Arabia, and how it is enhancing…

Saudi Arabia SAJA Pharmaceuticals is aiming to grow from a regional player to a multinational entity, in line with Saudi Arabia’s Vision 2030, leveraging strong partnerships, technology transfer, and strategic licensing to expand geographically. CEO Mohammed Khalil explains how the Saudi firm prides itself on its agility and commitment to high-quality, accessible…

Saudi Arabia Dr Walid Abbas Zaher highlights Saudi clinical trial Site Management Organisation (SMO) Carexso’s focus on addressing unmet needs in health economics, drug reinvestment modelling, and developing local talent. He emphasizes the importance of regional expertise and collaborations to advance R&D and envisions a robust local R&D ecosystem driven by competition…

Saudi Arabia SEHA Virtual Hospital, the world’s largest such network, brings together 170 hospitals and around 600 primary healthcare centers in Saudi Arabia. As the organisation’s CEO Eng. Mona Sahman Al-Subaie explains, SEHA provides a wide range of virtual medical services from critical care to specialised clinics, aimed at increasing the accessibility…